Here are relevant reports on : polymer-testing-market
-
Internet of Things (IoT) Testing Market by Testing Type (Functional, Performance, Network, Security, Compatibility, and Usability), Service Type (Professional and Managed), Application Type, and Region - Global Forecast to 2021
The IoT testing market size is estimated to grow from USD 302.9 Million in 2016 to USD 1,378.5 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 35.4%. The major forces driving the IoT testing market include the growing need for Internet Protocol (IP) testing of the increasing number of IoT devices and applications. Moreover, the need for shift left testing of IoT applications and the rising importance of DevOps are also some of the factors which are driving the market.
- Published: February 2017
- Price: $ 4950
- TOC Available:
-
Penetration Testing as a Service Market by Offering (Solution and Managed Services), Organization Size, Testing Types, Verticals (BFSI, Healthcare, IT & ITES, Telecommunications, Retail & E-Commerce, Manufacturing, Education) - Global Forecast to 2029
The global Penetration Testing as a Service (PTaaS) market size is projected to reach USD 301 million by 2029 at a CAGR of 20.5% during the forecast period. Synack (US), HackerOne (US), Synopsys (US), Intervision (US), Edgescan (Ireland), Bugcrowd (US), Guidepoint Security (US), Trustwave (US), Cobalt (US), NetSPI (US), Veracode (US), Yogosha (France), Software Secured (Canada), Raxis (US), Vumetric Cybersecurity (Canada), Nowsecure (US), Breachlock (US), Astra Security (India), Strobes Security (US), Pentest People (UK), Rootshell Security (UK), SafeAeon (US), Immuniweb (Switzerland), and Cyberhunter Solutions (Canada) are the key players and other players in the PTaaS market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030
The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Fire Testing Market by Service Type (Testing, Inspection, and Certification), Sourcing Type (In-house and Outsourced), Application (Consumer Goods & Retail, Chemicals, Construction & Infrastructure, Mining) Region - Global Forecast till 2025-2036
The global fire testing market was valued at USD 8.58 billion in 2024 and is projected to reach USD 17.85 billion by 2036, growing at a CAGR of 6.3% between 2025 and 2036.The key market players in the market are Intertek (UK), TUV SUD (Germany), IBM (US), SGS Group (Switzerland), Bureau Veritas SA (France), UL LLC (US), DEKRA SE (Germany), QIMA (Hong Kong), Applus+ (Spain), United Technologies (US), Element Materials Technology (UK), and International Fire Consultants Group (UK).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Global Forecast to 2022
The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The overall analytical laboratory services market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Elemental Analysis Market by Type (Organic, Inorganic), Technology (Destructive (ICP-AES, ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food and Beverage Testing, Environment Testing) - Analysis & Global Forecasts to 2020
The elemental analysis market is segmented on the basis of types, technologies, applications and regions. New international GMP and GDP certification ‘EXCiPACT’ for pharmaceutical excipients (North America & Europe), growing food safety concerns, increasing life science R&D spending, increasing use of X-ray fluorescence in medical research, and rise in use of Atomic Absorption Spectroscopy (AAS) to aid the drug safety process are major factors driving this market. In addition, the elemental analysis market has witnessed various technological advancements to meet the needs of biotechnology and biopharmaceutical companies; food and beverage, chemical, semiconductor industries; and environmental testing. The elemental analysis market is expected to reach $6.213 Billion in 2020 from $4.584 Billion in 2015, growing at a CAGR of 6.3%.
- Published: June 2015
- Price: $ 4950
- TOC Available:
-
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
The global healthcare analytical testing services market, valued at US$6.33 billion in 2023, stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$12.48 billion by the end of the period. The key factors contributing to market growth include stringent regulatory guidelines, a growing focus on analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical and medical device companies, and the rising acceptance of a quality-by-design approach in pharmaceutical research and manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
